Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 531 |
| Gross Profit | N/A | N/A | 531 |
| Operating Expenses | 19,290 | 0 | 18,013 |
| Operating Income | -19,290 | N/A | -17,482 |
| Interest Expense | 50 | 0 | 29 |
| Other Income | 683 | 0 | 456 |
| Pre-tax Income | -18,657 | 0 | -17,055 |
| Net Income Continuous | -18,657 | N/A | -17,055 |
| Net Income | $-18,657 | $N/A | $-17,055 |
| EPS Basic Total Ops | -11.58 | N/A | -10.38 |
| EPS Basic Continuous Ops | -11.58 | N/A | -10.38 |
| EPS Diluted Total Ops | -11.58 | N/A | -10.38 |
| EPS Diluted Continuous Ops | -11.58 | N/A | -10.38 |
| EBITDA(a) | $-18,843 | $N/A | $-17,482 |